Why the Evolution of Patient Advocacy Organizations Means Better Data For Your Rare Disease Trial

Patient communities are increasingly becoming more active players in rare disease clinical research. They fund basic research, develop contact registries, and have a network of investigators that can be utilized to advance development programs. In this article, learn more about how better partnerships with patient-led research organizations can improve treatments and advance trials.